Anything can happen at interim. Any result that's below p=0.03 will start to justify a halt, IMO. I'm leaning towards continuation for anything above, just to be conservative.

It's been stated several times already; mortality from what we know so far is highly anomalous... Significantly less participants have died in this trial than several others, as a whole. Something Is Up..